Updates in Medical Oncology 2026

Thursday, May 14, 2026, 8:00 AM - 4:30 PM, Dorrance H. Hamilton Building, Philadelphia, PA


AMA PRA Category 1 Credits™ (5.00 hours), AAPA Category 1 CME Credits (5.00 hours), ABS CC (5.00 hours), ACPE Contact Hour(s) (5.00 hours), ANCC Contact Hour(s) (5.00 hours), Non-Physician Attendance (5.00 hours)

Updates in Clinical Oncology will provide a review of recent development in the therapy of cancers and related diseases. Speakers will focus on emerging therapies in the clinical arena, including discussion of the practical aspects of therapy, supportive care and therapy related toxicities. Immunotherapies across all disease areas, cellular therapies in solid tumors and hematologic malignancies, innovative supportive care, and management of toxicities will be covered.

---

Keynote: Clifford Hudis, MD, FACP, FASCO

Dr. Hudis is the CEO of the American Society of Clinical Oncology (ASCO) and serves as executive vice chair of its Conquer Cancer Foundation. He oversees a staff of about 500 who serve a global membership of over 50,000 investigators and clinicians as they seek to reduce the burden of cancer through research, education, and the delivery of the highest quality care possible. ASCO holds the one of the world’s largest annual meetings focused on cancer research and care, publishes the high impact Journal of Clinical Oncology (and associated titles), supports and conducts research, defines optimal quality of care, and advocates for access for all. ASCO’s foundation, Conquer Cancer, funds more early-career physician scientists, without limits on geography or focus area, than any other independent cancer organization worldwide.

Prior to assuming his roles at ASCO in 2016, Dr. Hudis was the Chief of the Breast Cancer Medicine Service, Solid Tumor Division, and an Attending Physician at the Memorial Hospital for Cancer and Allied Diseases and a Professor of Medicine at the Joan & Sanford Weill Medical College of Cornell University Medical College both in New York City. Over nearly three decades, his team identified novel risk factors for cancer linked to inflammation and obesity and developed new drugs (G-CSF, taxanes, anti-HER2 agents) and regimens that raised the global standard of care across all stages of breast cancer.

---

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Thursday, June 4, 2026. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

---

1. Analyze recent advances in the delivery of immunotherapies to patients with cancers
2. Evaluate the of artificial intelligence in the management of patients with oncologic diseases.
3. Apply concepts in supportive care and integrative medicine to the care of patients with oncologic diseases.
4. Summarize the role of professional societies in driving change in the care of patients with cancer.
5. Explain the presentation and management of patients with thyroid cancer
6. Summarize the off target toxicities of immuno-therapies used in cancer care.

Type	Jefferson Fee	Non-Jefferson Fee
Physician Nurse/Nurse Practitioner Pharmacist Physician Assistant Other Healthcare Provider	$0 $0 $0 $0 $0	$100 $75 $75 $75 $75

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 5.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 5.00 nursing contact hours.

Pharmacists: This knowledge-based continuing education is designated for 5.00 credit contact hours of continuing education credit. JA4008236-0000-26-009-L01-P
Credits will be uploaded to CPE Monitor within 60 days following the completion of the activity. This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner's e-profile in CPE Monitor.

Physicians Assistants:

 

Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Other Healthcare Professionals: This educational activity is designated for 5.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Agenda
Agenda subject to change without notice.

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Dorrance H. Hamilton Building
Thomas Jefferson University
1001 Locust Street
Philadelphia, PA 19107

Directions

Parking

---

The virtual link will be posted on the Course tab.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Thursday, May 14, 2026

This educational activity received no commercial support.

Designed by the Jefferson Medical Oncology Department, this conference offers a prime opportunity for organizations to connect directly with oncology professionals. Attendees include faculty and clinical teams seeking the latest innovations that support cancer care, patient management, and clinical research.

Exhibitors gain visibility with clinicians who are actively integrating new therapies and technologies into practice. Throughout the day, there are multiple touchpoints to:

• Showcase products and educational materials

• Highlight solutions that enhance clinical decision-making

The conference delivers focused updates on emerging cancer therapies, supportive care strategies, and the evolving treatment landscape—attracting oncology teams looking to explore advancements shaping the future of practice.

Exhibit space at this symposium is in high demand and extremely limited. In addition to standard exhibit opportunities, one exclusive Product Theater presentation slot is available for an organization interested in delivering a featured session.

Application Deadline
Applications for exhibits will be accepted through May 4, 2026. After May 4, 2026, applications may be accepted on a case by case basis.

---

Exhibitor Rules

• Exhibitor is not providing commercial support for this activity; they are purchasing exhibit space only.

• All exhibits must be tabletop or portable in nature.

• Exhibitor activities are restricted to the designated space at the conference. Distribution of educational/promotional materials by the exhibitors is limited to their booth space in the exhibit area. It is not permitted anywhere else in the hall, conference meeting space, or at the entrances to the conference meeting space.

• Exhibits are intended for informational purposes only; products should not be sold onsite.

• Photography by exhibitors that include images of the conference or its attendees is prohibited.

• The purpose of the exhibit is to support attendee education through product and service displays and demonstrations. Exhibitor personnel may observe scientific sessions but may not participate in or record them on behalf of their company.

• Thomas Jefferson University is not responsible for the security of exhibitors’ materials. Exhibitors are advised not to leave valuables (e.g., laptops, cell phones) unattended at any time.

Cancellation by Conference Organizers
If the conference is cancelled, the organizers are not responsible for any airfare, hotel, or other costs incurred by exhibitors. The full exhibit fee paid by the company will be refunded.

Exhibitor Refund Request
Requests for exhibitor fee refunds must be submitted in writing and received by the Office of Continuing Professional Development (OCPD) at least one month before the conference start date. Cancellations received before this deadline will incur a 10% cancellation fee. No refunds will be issued after this period. All refunds will be processed after the conference.

Exhibitors who do not attend the conference will not receive a refund.

Send refund request to [email protected]. Include conference name in the subject line.

Exhibit at this Event